SERMScientificDirector

Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: [Our approach to R&D](https://www.gsk.com/en-gb/innovation/) Position Summary Provides advanced scientific expertise in the safety evaluation and risk management of key GSK oncology assets in clinical development. Leads the identification, assessment, and communication of safety risks to ensure robust benefit-risk profiles and protection of patients globally. This role plays a critical part in shaping the safety strategy of innovative oncology therapies, partnering cross-functionally to enable high-quality, timely decision-making and proactive risk mitigation across the portfolio. Key Responsibilities ### **Scientific and Pharmacovigilance Leadership** * Lead pharmacovigilance activities and risk mitigation strategies for assigned oncology assets and clinical trials * Drive the evaluation and interpretation of safety data, including signal detection and assessment * Develop strategic approaches for safety issue evaluation within clinical development programmes * Contribute to safety components of global regulatory submissions (e.g., INDs, DSURs, IBs) * Perform literature review, clinical data synthesis, and integrated safety analyses to inform decision-making * Ensure high-quality, timely delivery while managing multiple priorities ### **Cross-Functional Matrix Leadership** * Represent Safety Evalua